Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE | A210811 | CIPLA LIMITED
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ViiV Healthcare Company et al v. Cipla Limited et al 1 patentANDA 210811abacavir; dolutegravir sodium; lamivudine | D. Del. | 2017-11-17 | Terminated 2021-05-04 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.